Nanoparticles

Nanotechnology

Enhanced Cancer Treatment with Anti-HER2-Coated Paclitaxel-Loaded Immuno-Nanoparticles

Researchers from the University of Geneva, Switzerland, have discovered a new approach to cancer treatment using anti-HER2-coated paclitaxel-loaded immuno-nanoparticles. This innovative treatment was tested in a disseminated xenograft ovarian cancer model, where the therapeutic efficacy and biodistribution of the nanoparticles were evaluated. The study showed that the treatment, which consisted

Nanotechnology

Overcoming Multidrug Resistance in Breast Cancer Cells with Nano-Sized Micellar Doxorubicin Particles

Researchers at Chung Yuan Christian University have made significant progress in developing a novel approach to overcoming multidrug resistance (MDR) in breast cancer cells. By using nano-sized micellar doxorubicin particles, they have successfully demonstrated the potential of these nanoparticles to effectively deliver the anti-tumor drug doxorubicin into cancer cells, thereby

Nanotechnology

Breakthrough in Nanotechnology: Liposome-Encapsulated Paclitaxel/Fe3O4 Nanoparticles Show Promising Results

Researchers from Hanyang University in Gyeonggi Do, South Korea, have made significant advancements in the field of nanotechnology with their innovative liposome-enveloped paclitaxel/Fe3O4 nanoparticles. According to a study published in the Journal of Nanoscience and Nanotechnology, these nanoparticles demonstrate remarkable capabilities in targeted drug delivery and magnetic resonance imaging